Palmar plantar erythrodysesthesia historical perspective: Difference between revisions
Mchitsazan (talk | contribs) No edit summary |
Mchitsazan (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
{{Palmar plantar erythrodysesthesia}} | {{Palmar plantar erythrodysesthesia}} | ||
{{CMG}}, '''Associate Editor(s)-in-Chief:''' | {{CMG}}, '''Associate Editor(s)-in-Chief:''' [[Mandana Chitsazan, M.D.]] | ||
==Overview== | ==Overview== | ||
Line 8: | Line 8: | ||
In 1974, Zuehlke was the first to describe PPE in a patient receiving mitotane for hypernephroma. | In 1974, Zuehlke was the first to describe PPE in a patient receiving mitotane for hypernephroma. | ||
==References== | ==References== | ||
<references /> |
Revision as of 18:38, 26 June 2019
Palmar plantar erythrodysesthesia Microchapters |
Differentiating Palmar plantar erythrodysesthesia from other Diseases |
---|
Diagnosis |
Treatment |
Palmar plantar erythrodysesthesia historical perspective On the Web |
American Roentgen Ray Society Images of Palmar plantar erythrodysesthesia historical perspective |
FDA on Palmar plantar erythrodysesthesia historical perspective |
CDC on Palmar plantar erythrodysesthesia historical perspective |
Palmar plantar erythrodysesthesia historical perspective in the news |
Blogs on Palmar plantar erythrodysesthesia historical perspective |
Directions to Hospitals Treating Palmar plantar erythrodysesthesia |
Risk calculators and risk factors for Palmar plantar erythrodysesthesia historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Mandana Chitsazan, M.D.
Overview
Historical Perspective
In 1974, Zuehlke was the first to describe PPE in a patient receiving mitotane for hypernephroma.